Andra Ap Fonden Biogen Inc. Transaction History

Andra Ap Fonden

$6.89 Billion
Q2 2025

A detailed history of Andra Ap Fonden transactions in Biogen Inc. stock. As of the latest transaction made, Andra Ap Fonden holds 22,400 shares of BIIB stock, worth $3.35 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

22,400

Previous 46,200 51.52%

Holding current value

$3.35 Million

Previous $6.32 Million 55.5%

% of portfolio

0.04%

Previous 0.11%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$113.38 - $135.49 $2.7 Million - $3.22 Million	-23,800 Reduced 51.52%	22,400 $2.81 Million
Q1 2025 May 13, 2025	BUY	$133.43 - $153.27 $1.67 Million - $1.92 Million	12,500 Added 37.09%	46,200 $6.32 Million
Q4 2024 Feb 07, 2025	BUY	$146.47 - $191.55 $1.03 Million - $1.34 Million	7,000 Added 26.22%	33,700 $5.15 Million
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $434,861 - $544,640	2,300 Added 9.43%	26,700 $5.18 Million
Q2 2024 Aug 07, 2024	BUY	$190.52 - $236.72 $685,872 - $852,192	3,600 Added 17.31%	24,400 $5.66 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $2.16 Million - $2.73 Million	-10,200 Reduced 32.9%	20,800 $4.49 Million
Q4 2023 Feb 15, 2024	SELL	$222.59 - $267.94 $222,590 - $267,940	-1,000 Reduced 3.13%	31,000 $8.02 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $1.32 Million - $1.49 Million	-5,200 Reduced 13.98%	32,000 $8.22 Million
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $6.36 Million - $7.35 Million	-23,100 Reduced 38.31%	37,200 $10.6 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $2.59 Million - $2.95 Million	10,100 Added 20.12%	60,300 $16.8 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $2.88 Million - $3.5 Million	11,400 Added 29.38%	50,200 $13.9 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $2.22 Million - $3.06 Million	-11,400 Reduced 22.71%	38,800 $10.4 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.91 Million - $2.27 Million	-10,200 Reduced 16.89%	50,200 $10.2 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $694,152 - $892,087	-3,100 Reduced 4.88%	60,400 $14.5 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $1.25 Million - $1.62 Million	4,400 Added 7.45%	63,500 $18 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $1.63 Million - $2.61 Million	6,300 Added 11.93%	59,100 $20.5 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $1.51 Million - $1.76 Million	-6,200 Reduced 10.51%	52,800 $14.8 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $5.46 Million - $8.22 Million	23,100 Added 64.35%	59,000 $14.4 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $185,339 - $213,997	-700 Reduced 1.91%	35,900 $10.2 Million
Q2 2020 Aug 06, 2020	BUY	$258.66 - $342.55 $1.06 Million - $1.4 Million	4,100 Added 12.62%	36,600 $9.79 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $752,780 - $954,912	2,800 Added 9.43%	32,500 $10.3 Million
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $506,138 - $699,361	-2,300 Reduced 7.19%	29,700 $8.81 Million
Q3 2019 Nov 19, 2019	SELL	$217.44 - $243.88 $674,064 - $756,028	-3,100 Reduced 8.83%	32,000 $7.45 Million
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $1.21 Million - $1.33 Million	5,500 Added 18.58%	35,100 $8.21 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $736,814 - $1.15 Million	-3,400 Reduced 10.3%	29,600 $7 Million
Q3 2018 Oct 16, 2018	SELL	$293.51 - $383.83 $557,669 - $729,277	-1,900 Reduced 5.44%	33,000 $11.7 Million
Q2 2018 Aug 17, 2018	BUY	$257.52 - $306.91 $1.83 Million - $2.18 Million	7,100 Added 25.54%	34,900 $10.1 Million
Q1 2018 Apr 10, 2018	BUY	$260.13 - $367.91 $4.14 Million - $5.85 Million	15,900 Added 133.61%	27,800 $7.61 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $953,684 - $1.07 Million	-3,100 Reduced 20.67%	11,900 $3.79 Million
Q3 2017 Oct 31, 2017	BUY	$281.15 - $329.69 $4.22 Million - $4.95 Million	15,000	15,000 $4.7 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

131M

Call Options Held

2.84M

Put Options Held

2.54M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account